Clinical Trial

The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2024 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The incidence of Chronic kidney disease (CKD) is showing an upward trend, but the therapeutic effect of treatment is limited. Remote ischemic conditioning (RIC) has the potential to safeguard remote organs via the repeated application of brief ischemic stimuli. the aim of our study is to investigate whether RIC can protect the renal function in patients with CKD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-08.
Trial Details
NCT Number NCT06501222
Lead Sponsor Yuanjun Yang
Conditions Chronic Kidney Diseases
Enrollment 114 participants
Start Date 2024-03-01
Primary Completion 2026-03-30 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-19